The identifier "SPCC794.04c" aligns with systematic naming conventions for yeast genomic constructs:
SPCC: Likely refers to Schizosaccharomyces pombe (fission yeast) chromosomal coordinates or strain designations.
794.04c: Suggests a specific chromosomal locus (794 kb region) with additional annotations (04c) for gene variants or constructs.
This pattern matches strain/plasmid identifiers in S. pombe studies, such as those investigating cell wall biosynthesis proteins (e.g., Sup11p) .
A study on S. pombe Sup11p (a protein involved in cell wall integrity) references polyclonal antibodies raised against GST-fusion peptides of Sup11p . Key findings include:
| Parameter | Findings |
|---|---|
| Target Protein | Sup11p (hypothesized O-mannosyltransferase) |
| Antibody Application | Western blot, immunofluorescence, antigen purification |
| Functional Role | Essential for viability; depletion causes aberrant septal glucan deposition |
| Cell Wall Remodeling | Upregulation of glucanases (Gas2p) and altered glycosylation patterns |
| Genetic Interactions | Suppresses O-mannosylation mutants (e.g., oma4Δ) |
If "SPCC794.04c" refers to a Sup11p-associated construct, the corresponding antibody would likely:
Target: Sup11p or its modified isoforms.
Applications:
Validation:
Specificity confirmed via knockout controls (e.g., sup11Δ strains).
Cross-reactivity tested against related enzymes (e.g., Gas1p, Bgs4p).
No publications explicitly describe an antibody named "SPCC794.04c."
Antibodies referenced in S. pombe studies are typically polyclonal or custom-made for specific projects .
Commercial databases (e.g., Sino Biological, Abcam) lack entries for this identifier .
To validate the existence and utility of "SPCC794.04c Antibody":
Contact Authors: Reach out to researchers in S. pombe cell wall studies (e.g., institutions cited in ).
Screen Repositories: Query antibody banks (e.g., Addgene, ATCC) for unpublished S. pombe reagents.
Replicate Protocols: Review supplemental materials of S. pombe studies for antibody generation methods .
KEGG: spo:SPCC794.04c
STRING: 4896.SPCC794.04c.1
SPCC794.04c is a protein encoded on chromosome C in Schizosaccharomyces pombe (fission yeast). While the specific function of SPCC794.04c is not directly detailed in the available literature, proteins in this genomic region are frequently associated with important cellular processes. Similar proteins from the same chromosome, such as SPCC794.12c and SPCC794.11c, have been studied in the context of gene expression regulation and protein complex formation . Many proteins in the SPCC family are involved in critical cellular functions including chromosome organization, cell division, and stress responses. Understanding SPCC794.04c requires contextualizing it within the broader landscape of fission yeast proteomics and gene expression studies.
Based on research practices with similar antibodies, SPCC794.04c antibody is likely suitable for several applications including immunohistochemistry on paraffin-embedded tissues (IHC-P), western blotting, and potentially immunoprecipitation assays . When selecting an antibody for specific applications, researchers should verify the validation data provided by manufacturers. For example, antibodies like the SCP1 antibody have been validated for IHC-P with specific retrieval conditions (heat-mediated antigen retrieval with EDTA buffer pH 9) . Always review the validation data for the specific lot of SPCC794.04c antibody to ensure it has been tested for your intended application.
SPCC794.04c is a fission yeast (S. pombe) protein, so primary reactivity would be expected against this species. Cross-reactivity with proteins from other yeast species might occur depending on sequence conservation. When working with antibodies targeting specific proteins, reactivity predictions should be based on sequence homology analysis . For example, antibodies like anti-SCP1 are specifically tested against human samples, with predictions for other species based on homology . Researchers should carefully evaluate sequence alignment data between SPCC794.04c and potential target proteins in other species before attempting cross-species applications.
When investigating protein complexes involving SPCC794.04c, researchers should consider multiple complementary approaches. Affinity-purification mass spectrometry (AP-MS) represents a powerful technique for identifying interaction partners . This methodology involves:
Immunoprecipitation using the SPCC794.04c antibody
Mass spectrometric analysis of co-precipitated proteins
Bioinformatic filtering to remove common contaminants
Validation of interactions through reciprocal pulldowns
Researchers should be aware that protein complex assembly dynamics can significantly impact experimental outcomes. Studies have shown that proteins within the same complex often exhibit coordinated degradation patterns, with complex-assembled proteins showing non-exponential degradation kinetics compared to unbound subunits . When designing experiments to study SPCC794.04c complexes, consider both the stoichiometry and assembly timing of potential interaction partners.
Studying SPCC794.04c in aneuploid contexts requires careful experimental design due to dosage effects. Research has demonstrated that protein abundance in aneuploid cells does not always directly scale with gene copy number . If SPCC794.04c participates in heteromeric protein complexes, its expression level may be attenuated compared to theoretical expectations when its encoding chromosome is duplicated .
The degree of attenuation often correlates with complex size - proteins in larger complexes typically show greater attenuation when overexpressed due to aneuploidy . When designing experiments:
Include appropriate diploid controls
Measure both transcript and protein levels
Consider the stoichiometry of all complex members
Be aware that late-binding subunits in complex assembly show less attenuation than early-binding components
Table 1: Factors affecting protein attenuation in aneuploid cells
| Factor | Effect on Attenuation | Relevance to SPCC794.04c Studies |
|---|---|---|
| Complex size | Larger complexes = greater attenuation | Determine if SPCC794.04c is part of a multi-subunit complex |
| Assembly timing | Early-binding subunits more attenuated | Establish SPCC794.04c position in assembly hierarchy |
| Protein disorder | Higher disorder = greater attenuation | Analyze SPCC794.04c structural properties |
| Interface size | Larger interfaces = less attenuation | Characterize SPCC794.04c binding interfaces |
Antibody specificity is crucial for reliable experimental outcomes. When encountering specificity issues with SPCC794.04c antibody, implement the following systematic troubleshooting approach:
Validate antibody specificity using a knockout or knockdown control
Perform peptide competition assays to confirm epitope specificity
Test multiple antibodies targeting different epitopes of SPCC794.04c
Use orthogonal detection methods to confirm results
Recent research emphasizes the importance of validating antibody specificity, particularly in studies targeting multiple proteins simultaneously . Cross-reactivity can significantly compromise data interpretation, especially when studying closely related proteins. Always include appropriate negative controls and consider using recombinant monoclonal antibodies which typically offer improved specificity compared to polyclonal alternatives .
For optimal immunohistochemistry results with SPCC794.04c antibody, consider the following protocol based on practices with similar antibodies:
Tissue preparation:
Fix tissue samples in 10% neutral-buffered formalin
Process and embed in paraffin
Section at 4-5 μm thickness
Antigen retrieval:
Perform heat-mediated antigen retrieval using EDTA buffer (pH 9.0)
Heat sections at 95-98°C for 20 minutes in retrieval solution
Allow gradual cooling to room temperature
Antibody incubation:
Optimization may be required for specific tissue types or fixation conditions. Always include positive and negative controls to validate staining specificity. When analyzing results, quantify staining intensity and distribution systematically to ensure reproducibility .
To investigate SPCC794.04c degradation kinetics, especially in the context of protein complex assembly, consider the following experimental design:
Pulse-chase analysis:
Metabolically label cells with stable isotopes
Chase with non-labeled media for various time periods
Quantify labeled SPCC794.04c using mass spectrometry
Proteasome inhibition studies:
Treat cells with proteasome inhibitors (e.g., MG132)
Monitor SPCC794.04c levels with western blotting
Compare degradation patterns between free and complex-bound populations
Analysis framework:
Research has demonstrated that many proteins in heteromeric complexes exhibit non-exponential degradation (NED) patterns, with complex-bound subunits showing different degradation rates compared to unbound subunits . When studying SPCC794.04c degradation, evaluate whether it follows exponential or non-exponential kinetics, as this may provide insights into its participation in protein complexes.
If SPCC794.04c is involved in chromatin organization (like many proteins in fission yeast), consider these methodological approaches:
Chromatin immunoprecipitation (ChIP):
Cross-link protein-DNA interactions in vivo
Immunoprecipitate using SPCC794.04c antibody
Identify DNA binding sites through sequencing (ChIP-seq)
Analyze enrichment patterns relative to genomic features
Chromosome conformation capture techniques:
Implement Hi-C or similar approaches to map chromatin interactions
Correlate SPCC794.04c binding sites with chromatin architecture
Use spike-in controls for quantitative comparisons between conditions
Microscopy-based approaches:
When designing these experiments, consider that chromatin-associated proteins often function within larger complexes. Studies on proteins like Swi6 (HP1 homolog) demonstrate how chromatin factors respond to genomic alterations in aneuploid states, potentially affecting gene expression and chromosome organization .
When facing contradictory results about SPCC794.04c function, implement this systematic approach:
Context evaluation:
Compare experimental conditions between contradictory studies
Assess differences in cell types, growth conditions, or genetic backgrounds
Evaluate the sensitivity and specificity of detection methods used
Technical validation:
Replicate key experiments using multiple methodologies
Implement quantitative approaches with appropriate statistical analyses
Consider genetic approaches (knockout/knockdown) to complement antibody-based studies
Resolution strategies:
Research on protein function often reveals context-dependent roles. For example, studies on gene expression in aneuploid cells demonstrate that the same protein may behave differently depending on the stoichiometry of its interaction partners . When integrating contradictory data about SPCC794.04c, consider that it may have multiple functions depending on cellular context or interaction partners.
To analyze SPCC794.04c interaction networks effectively, consider these bioinformatic approaches:
Network construction and visualization:
Integrate experimental interaction data from multiple sources
Apply confidence scoring to prioritize high-quality interactions
Visualize networks using platforms like Cytoscape with appropriate layouts
Functional enrichment analysis:
Identify significantly enriched biological processes among interactors
Implement Gene Ontology and pathway analysis
Consider protein domain enrichment for mechanistic insights
Evolutionary analysis:
When analyzing protein interaction networks, recent research emphasizes the importance of considering both direct physical interactions and functional associations. Studies on protein complexes demonstrate that subunits often share evolutionary histories and expression patterns . Apply these principles when interpreting SPCC794.04c interaction data to distinguish between core complex members and transient interactors.
Several cutting-edge technologies hold promise for advancing SPCC794.04c research:
Proximity labeling approaches:
BioID or APEX2 fusion proteins to identify proximal interactors
Spatial and temporal mapping of SPCC794.04c microenvironment
Identification of transient or context-specific interactions
Cryo-electron microscopy:
CRISPR-based technologies:
Precise genome editing to introduce tags or mutations
CUT&RUN/CUT&Tag for high-resolution chromatin mapping
Optogenetic control of SPCC794.04c function in living cells
These technologies can overcome limitations of traditional antibody-based approaches, providing enhanced spatial, temporal, and molecular resolution. When designing future studies, consider how these methods might address current knowledge gaps about SPCC794.04c function, particularly in understudied cellular contexts or stress conditions .
If investigating SPCC794.04c homologs in disease contexts, consider these guiding principles:
Model selection rationale:
Choose disease models with aberrations in the pathway involving SPCC794.04c
Consider aneuploidy-associated conditions if appropriate
Evaluate conservation between SPCC794.04c and human homologs
Experimental design considerations:
Include appropriate genetic controls (rescue experiments)
Assess both loss and gain of function phenotypes
Monitor both acute and chronic effects of altered expression
Translational research approaches:
Research on aneuploid cells provides valuable insights into how protein imbalances affect cellular function and potentially contribute to disease states. Studies have demonstrated that aneuploidy leads to increased protein aggregation, particularly affecting members of heteromeric complexes . These principles may guide investigations into how SPCC794.04c dysregulation might contribute to cellular dysfunction in disease contexts.